EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

[18F]SynVest-1 PET imaging in people with Parkinson’s disease

Sarah L Martin iD, Carme Uribe, Kimberly L Desmond, Lucas Narciso, Bayla Dolman, Edgardo Torres-Carmona, Isabelle Boileau, Ariel Graff-Guerrero, Neil Vasdev iD, Antonio P Strafella

Brain Communications · 03.07.2025 · 7 (4)

DOI: 10.1093/braincomms/fcaf258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Communications, online erschienen am 16.07.2025. Verfasst von Sarah L Martin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, 27 King's College Circle, Toronto, Ontario M5S 1A1, Canada. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J. Fox Foundation, Weston Brain Institute, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The [18F]SynVest-1 radiotracer targets the synaptic vesicle glycoprotein 2A (SV2A) and is a proxy of presynaptic density. Parkinson’s disease is associated with synaptic dysfunction. Here we investigated synaptic density via the [18F]SynVest-1 radiotracer in people with PD compared with healthy controls, with reference to how it compares to the previous SV2A radiotracer, [11C]UCB-J. Ten Parkinson’s patients and 12 healthy subjects underwent a [18F]SynVest-1 PET scan. We compared non-displaceable binding potential via voxel-wise and volume of interest analysis to investigate group differences. Volume-of-interest-analyses reported lower non-displaceable binding potential in key a priori regions associated with Parkinson’s disease, namely the substantia nigra and caudate nucleus (P < 0.05). Follow-up exploratory volume-of-interest-analyses reported widespread reduction in non-displaceable binding potential within all brain lobes, cerebellum, hippocampus, thalamus and insula; however, these findings did not survive correction for multiple comparisons (P < 0.004). In addition, voxel-wise analyses with family-wise error correction, highlighted significantly lower non-displaceable binding potential in the PD cohort within the putamen and cerebellum. We did not observe any relationships between clinical metrics and non-displaceable binding potential. The results are in line with differences observed using the [11C]UCB-J radiotracer. The [18F]SynVest-1 radiotracer confirmed lower synaptic density in the Parkinson’s disease cohort and adds to the growing evidence of synaptic dysfunction in Parkinson’s disease pathology.

Schlagwörter

Stichwörter der Autor:innen

PETParkinson’s diseaseSV2A[18F]SynVest-1synaptic densitysynaptic vesicle glycoprotein 2A

Autor:innen und Institutionen

  • Temerty Faculty of Medicine, University of Toronto, 27 King's College Circle, Toronto, Ontario M5S 1A1, Canada.
  • Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto M5T 1R8, Canada.
  • Department of Psychology, Faculty of Health and Education, Translational and Computational Neuroscience Unit, Manchester Metropolitan University, Manchester M15 6GX, UK.
  • Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Ontario M5T 1S8, Canada.
  • Department of Psychiatry, University of Toronto, Toronto M5T 1R8, Canada.
  • Neurology Division, Department of Medicine, Morton and Gloria Shulman Movement Disorder Unit and Edmond J. Safra Program in Parkinson Disease, Toronto Western Hospital, University Health Network, University of Toronto,…

ORCID-Profile: Sarah L Martin, Neil Vasdev

Förderung

  • Michael J. Fox Foundation
  • Weston Brain Institute
  • Canadian Institutes of Health Research
  • Krembil-Rossy Chair programme
  • Azrieli Foundation
  • Canada Research Chairs Programme
  • Canada Foundation for Innovation
  • Ontario Research Fund

Zitieren

APA

Martin, S. L., Uribe, C., Desmond, K. L., Narciso, L., Dolman, B., Torres-Carmona, E., Boileau, I., Graff-Guerrero, A., Vasdev, N., & Strafella, A. P. (2025). [18F]SynVest-1 PET imaging in people with Parkinson’s disease. Brain Communications, 7(4). https://doi.org/10.1093/braincomms/fcaf258

Vancouver

Martin SL, Uribe C, Desmond KL, Narciso L, Dolman B, Torres-Carmona E, et al. [18F]SynVest-1 PET imaging in people with Parkinson’s disease. Brain Communications. 2025;7(4). doi:10.1093/braincomms/fcaf258

BibTeX
@article{Martin2025,
  author = {Martin, Sarah L and Uribe, Carme and Desmond, Kimberly L and Narciso, Lucas and Dolman, Bayla and Torres-Carmona, Edgardo and Boileau, Isabelle and Graff-Guerrero, Ariel and Vasdev, Neil and Strafella, Antonio P},
  title = {[18F]SynVest-1 PET imaging in people with Parkinson’s disease},
  journal = {Brain Communications},
  year = {2025},
  volume = {7},
  number = {4},
  doi = {10.1093/braincomms/fcaf258}
}
Kostenlos starten →